Keurig Dr Pepper reported first-quarter revenue and profit above Wall Street expectations on Thursday, helped by strong ...

Keurig Dr Pepper beat profit and sales estimates as demand for its U.S. soft drinks jumped. U.S. coffee revenue slid, hurt by ...

Keurig Dr Pepper reports 4.8% sales growth, driven by U.S. Refreshment success and strategic initiatives. EPS beats estimates ...

Q1 2025 Management View CEO Tim Cofer highlighted a strong start to 2025, with net sales increasing over 6% and EPS rising ...

Stream sniping—where viewers deliberately join or disrupt a live stream—has become increasingly common as IRL live streaming ...

A mom is suing a Missouri school for suspending her 13-year-old son for making a rifle out of cans of Dr. Pepper and then ...

Strikes at a Keurig Dr Pepper factory in Iowa have ended after the company provided a new wage offer and guaranteed time off.

Barclays analyst Lauren Lieberman maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report) today and set a price target of $37.00.

The company said, “KDP reaffirmed its fiscal 2025 guidance for constant currency net sales growth in a mid-single-digit range and Adjusted ...

In proof that you can’t make everyone happy all of the time, soda fans are rebelling against a new Dr Pepper flavor.

Keurig Dr Pepper beats Q1 estimates and reaffirms FY25 outlook, as strong beverage growth offsets coffee sales decline.

Keurig Dr Pepper shares rose Tuesday after the soft drink and coffee company revealed in a regulatory filing that it has secured a new $4 billion revolving credit agreement.